Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,171) with videos related to
Page
of 118
Sort By:
Cancer Research
|
May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
Yifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Critical Care (London, England)
|
October 20, 2017
Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis
Namkje A R Vellinga, E Christiaan Boerma, Matty Koopmans, et al.
Nature Cancer
|
April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Katherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
BMJ (Clinical Research Ed.)
|
October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Critical Care (London, England)
|
February 8, 2013
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, et al.
The New England Journal of Medicine
|
July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
William D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors
Domiziana Cecchini, AkshatKumar Nigam, Ming Tang, et al.
Cancer Discovery
|
April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
James M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
JCI Insight
|
November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Vaccines
|
May 25, 2024
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
Han Di, Elizabeth A Pusch, Joyce Jones, et al.
Page
of 118
Search research articles
Search
Showing results (1111-1120 of 1,171) with videos related to
Sort By:
Page
of 118
Cancer Research
|
May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
Yifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Critical Care (London, England)
|
October 20, 2017
Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis
Namkje A R Vellinga, E Christiaan Boerma, Matty Koopmans, et al.
Nature Cancer
|
April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Katherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
BMJ (Clinical Research Ed.)
|
October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Critical Care (London, England)
|
February 8, 2013
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, et al.
The New England Journal of Medicine
|
July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
William D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors
Domiziana Cecchini, AkshatKumar Nigam, Ming Tang, et al.
Cancer Discovery
|
April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma
James M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
JCI Insight
|
November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Vaccines
|
May 25, 2024
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
Han Di, Elizabeth A Pusch, Joyce Jones, et al.
Page
of 118